BioSyent (CVE:RX) Sets New 52-Week High – Should You Buy?

BioSyent Inc. (CVE:RX)’s share price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as C$16.25 and last traded at C$16.16, with a volume of 1571 shares traded. The stock had previously closed at C$15.99.

BioSyent Trading Up 0.8%

The company has a debt-to-equity ratio of 6.85, a quick ratio of 6.91 and a current ratio of 2.07. The firm has a 50 day simple moving average of C$14.89 and a two-hundred day simple moving average of C$14.76. The firm has a market capitalization of C$180.94 million, a P/E ratio of 18.74 and a beta of 1.00.

Insiders Place Their Bets

In other BioSyent news, Director Seyed Ahmad Ashrafi sold 1,884 shares of the company’s stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of C$14.65, for a total value of C$27,600.60. Following the completion of the sale, the director directly owned 37,261 shares of the company’s stock, valued at approximately C$545,873.65. This represents a 4.81% decrease in their position. Insiders have sold 5,509 shares of company stock worth $82,004 in the last 90 days. 33.65% of the stock is currently owned by insiders.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis.